$66M sweet spot round size
Most of their 8 investments are in rounds between $19M and $77M
2018
Perceive Biotherapeutics, Inc. raised $78M on January 5, 2023
Investors: Catalio Capital Management, Braidwell and RD Fund
SparingVision raised $75M on September 14, 2022
Investors: UPMC Enterprises, Ysios Capital, JEITO and RD Fund
NACUITY PHARMACEUTICALS, INC. raised $17M on June 15, 2022
Investors: Maxim Group and RD Fund
SalioGen Therapeutics raised $115M on January 5, 2022
Investors: GordonMD Global Investments LP, T. Rowe Price, EPIQ, D1 Capital Partners L.P. and RD Fund
Undisclosed raised $19M on September 22, 2021
Investors: Bios Partners and RD Fund
Vedere Bio II raised $77M on May 18, 2021
Investors: Octagon Capital Advisors, Samsara BioCapital, Casdin Capital, LLC, Atlas Venture and RD Fund
Atsena Therapeutics raised $55M on December 16, 2020
Investors: Abingworth, Sofinnova Ventures, Russia technology fund, Lightstone Ventures, Osage University Partners (OUP) and RD Fund
Undisclosed raised $57M on November 9, 2020
Investors: Novo Holdings, venBio Partners, Pontifax Venture Capital, Canaan and RD Fund